Sunday 23 September 2018
Contact US    |    Archive
Channel News Asia
1 months ago

Japan s Eisai gains US approval for liver cancer treatment

REUTERS: Japan s Eisai Co Ltd on Thursday received U.S. approval for a therapy for previously untreated patients with a common form of liver cancer, paving the way for multibillion dollar sales. The oral drug, Lenvima, was jointly developed with Merck and Co Inc to treat unresectable hepatocellular ...

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

That ’70s style

- inquirer

The book of Jake

- inquirer

Love, interrupted

- inquirer
Hashtags:   

Japan

 | 

Eisai

 | 

gains

 | 

approval

 | 

for

 | 

liver

 | 

cancer

 | 

treatment

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)